Wednesday, March 4, 2009

R.I.P. Zero Stage Capital

Cambridge-based early-stage investor Zero Stage Capital has been functionally defunct for a few years now, but Venture Wire today has the official obituary. (Thanks to Keith Cline for the link.)

Jonathan Matsey of Venture Wire writes:

    ...[S]everal other companies from Zero Stage's portfolio are still privately held: cytometer maker CompuCyte Inc., site management company First Service Networks Inc., spinal device maker HydroCision Inc., motion technology company InterSense Inc., college administration system manager Jenzabar Inc., solar technology company Konarka Technologies Inc., kiosk software developer NetKey Inc., pollution control company Powerspan Corp. and DNA analysis company U.S. Genomics Inc.

    One LP says returns from one of the life science and IT firm's funds were "a disaster."

Labels: ,